Low Grade Serous Carcinoma clinical trials at University of California Health

1 research study open to eligible people

Ribociclib and Letrozole Treatment in Ovarian Cancer
open to eligible females ages 18 years and up
The study evaluates the response to treatment with Ribociclib and Letrozole in patients with low grade serous cancer of the ovary, fallopian tube or peritoneum.
at UCSF

Last updated: February 15, 2022